Brand Name | Status | Last Update |
---|---|---|
aminosyn-pf | New Drug Application | 2022-07-21 |
gze yellow peeling oil | C200263 | 2024-11-10 |
lingtea | unapproved drug other | 2018-06-24 |
premasol - sulfite-free (amino acid) | ANDA | 2022-08-04 |
trophamine | New Drug Application | 2023-11-27 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-small-cell lung carcinoma | D002289 | — | — | 1 | — | — | — | — | 1 |
Lung neoplasms | D008175 | — | C34.90 | 1 | — | — | — | — | 1 |
Brain neoplasms | D001932 | EFO_0003833 | C71 | 1 | — | — | — | — | 1 |
Melanoma | D008545 | — | — | 1 | — | — | — | — | 1 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | 1 | — | — | — | — | 1 |
Drug common name | Taurine |
INN | taurine |
Description | Taurine is an amino sulfonic acid that is the 2-amino derivative of ethanesulfonic acid. It is a naturally occurring amino acid derived from methionine and cysteine metabolism. An abundant component of fish- and meat-based foods, it has been used as an oral supplement in the treatment of disorders such as cystic fibrosis and hypertension. It has a role as a human metabolite, an antioxidant, a mouse metabolite, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a glycine receptor agonist, a nutrient and a radical scavenger. It is a conjugate acid of a 2-aminoethanesulfonate. It is a tautomer of a taurine zwitterion. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | NCCS(=O)(=O)O |
PDB | — |
CAS-ID | 107-35-7 |
RxCUI | — |
ChEMBL ID | CHEMBL239243 |
ChEBI ID | 15891 |
PubChem CID | 1123 |
DrugBank | DB01956 |
UNII ID | 1EQV5MLY3D (ChemIDplus, GSRS) |